Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2026-02-06 @ 6:04 AM
Study NCT ID:
NCT01397305
Status:
COMPLETED
Last Update Posted:
2020-09-09
First Post:
2011-05-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Sponsor:
Isofol Medical AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ISO-MC-091
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None